BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 24532422)

  • 1. Genomic and transcriptional alterations of cholangiocarcinoma.
    Ito T; Sakurai-Yageta M; Goto A; Pairojkul C; Yongvanit P; Murakami Y
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):380-7. PubMed ID: 24532422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of Opisthorchis viverrini-related cholangiocarcinoma.
    Jusakul A; Kongpetch S; Teh BT
    Curr Opin Gastroenterol; 2015 May; 31(3):258-63. PubMed ID: 25693006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of KRAS and TP53 in a minor proportion of Opisthorchis viverrini-associated cholangiocarcinomas in a hamster model.
    Tangkawattana S; Kaewkes S; Pairojkul C; Tangkawattana P; Sripa B
    Asian Pac J Cancer Prev; 2008; 9(1):101-6. PubMed ID: 18439086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma.
    Jinawath N; Chamgramol Y; Furukawa Y; Obama K; Tsunoda T; Sripa B; Pairojkul C; Nakamura Y
    Hepatology; 2006 Oct; 44(4):1025-38. PubMed ID: 17006947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.
    Yongvanit P; Pinlaor S; Loilome W
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model.
    Loilome W; Yongvanit P; Wongkham C; Tepsiri N; Sripa B; Sithithaworn P; Hanai S; Miwa M
    Mol Carcinog; 2006 May; 45(5):279-87. PubMed ID: 16550611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma.
    Kongpetch S; Jusakul A; Lim JQ; Ng CCY; Chan JY; Rajasegaran V; Lim TH; Lim KH; Choo SP; Dima S; Popescu I; Duda DG; Kukongviriyapan V; Khuntikeo N; Pairojkul C; Rozen SG; Tan P; Teh BT
    JCO Glob Oncol; 2020 Apr; 6():628-638. PubMed ID: 32315234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways.
    Kongpetch S; Jusakul A; Ong CK; Lim WK; Rozen SG; Tan P; Teh BT
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):233-44. PubMed ID: 25966424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTHFR polymorphisms and Opisthorchis viverrini infection: a relationship with increased susceptibility to cholangiocarcinoma in Thailand.
    Songserm N; Promthet S; Sithithaworn P; Pientong C; Ekalaksananan T; Chopjitt P; Parkin DM
    Asian Pac J Cancer Prev; 2011; 12(5):1341-5. PubMed ID: 21875294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma.
    Boonjaraspinyo S; Wu Z; Boonmars T; Kaewkes S; Loilome W; Sithithaworn P; Nagano I; Takahashi Y; Yongvanit P; Bhudhisawasdi V
    Parasitol Int; 2012 Mar; 61(1):145-50. PubMed ID: 21777692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of liver fluke infection as risk factor for cholangiocarcinoma.
    Sithithaworn P; Yongvanit P; Duenngai K; Kiatsopit N; Pairojkul C
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):301-8. PubMed ID: 24408775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinoma.
    Saengboonmee C; Seubwai W; Wongkham C; Wongkham S
    Cancer Epidemiol; 2015 Jun; 39(3):274-8. PubMed ID: 25910864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
    Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms.
    Songserm N; Promthet S; Sithithaworn P; Pientong C; Ekalaksananan T; Chopjitt P; Parkin DM
    Cancer Epidemiol; 2012 Apr; 36(2):e89-94. PubMed ID: 22189445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Potential Biomarkers for
    Aksorn N; Roytrakul S; Kittisenachai S; Leelawat K; Chanvorachote P; Topanurak S; Hamano S; Lek-Uthai U
    In Vivo; 2018; 32(4):871-878. PubMed ID: 29936472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.
    Chan-On W; Nairismägi ML; Ong CK; Lim WK; Dima S; Pairojkul C; Lim KH; McPherson JR; Cutcutache I; Heng HL; Ooi L; Chung A; Chow P; Cheow PC; Lee SY; Choo SP; Tan IB; Duda D; Nastase A; Myint SS; Wong BH; Gan A; Rajasegaran V; Ng CC; Nagarajan S; Jusakul A; Zhang S; Vohra P; Yu W; Huang D; Sithithaworn P; Yongvanit P; Wongkham S; Khuntikeo N; Bhudhisawasdi V; Popescu I; Rozen SG; Tan P; Teh BT
    Nat Genet; 2013 Dec; 45(12):1474-8. PubMed ID: 24185513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke
    Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B
    Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand.
    Sriamporn S; Pisani P; Pipitgool V; Suwanrungruang K; Kamsa-ard S; Parkin DM
    Trop Med Int Health; 2004 May; 9(5):588-94. PubMed ID: 15117303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for Opisthorchis viverrini Infection in Nong Khai Province, Thailand.
    Chudthaisong N; Promthet S; Bradshaw P
    Asian Pac J Cancer Prev; 2015; 16(11):4593-6. PubMed ID: 26107209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High excretion of etheno adducts in liver fluke-infected patients: protection by praziquantel against DNA damage.
    Dechakhamphu S; Yongvanit P; Nair J; Pinlaor S; Sitthithaworn P; Bartsch H
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1658-64. PubMed ID: 18628417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.